JG
NYMX

Jefferies Group’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Jefferies Group’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-14,600
Closed -$34K – 2178
2020
Q1 		$34K Buy
+14,600
New +$41K ﹤0.01% 1906

Other funds holding NYMX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $25.2B AUM 30.31% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Jefferies Group's NYMX Position: Q2 2020 in Review

Jefferies Group sold out of Nymox Pharmaceutical Corp (NYMX) in Q2 2020, closing a stake of 14,600 shares — an estimated $34K sold.

Jefferies Group first reported a position in NYMX in Q1 2020 and held it in 1 quarter. The position peaked at $34K in Q1 2020. 63 funds tracked by Wall St. Rank hold NYMX as of Q2 2020.

  • Jefferies Group reported no remaining Nymox Pharmaceutical Corp position as of Q2 2020 after selling out during the quarter.
  • Jefferies Group sold 14,600 Nymox Pharmaceutical Corp shares in Q2 2020, an estimated $34K.
  • Jefferies Group first reported a position in Nymox Pharmaceutical Corp in Q1 2020 and held it in 1 quarter.
  • Jefferies Group's Nymox Pharmaceutical Corp position peaked at $34K in Q1 2020.
  • 63 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2020.

Based on Jefferies Group's 13F filing for Q2 2020, filed 14 Aug 2020.